CVS Health: 8x P/E, 8% Growth Projection - It's A Market Blind Spot

sturti/E+ via Getty ImagesMedicare Advantage headwind CVS Health Corporation (NYSE:CVS) has been facing some pretty strong headwinds recently. More specifically, the following chart shows the investment returns from CVS stock with a comparison against the broader market (approximated by SPY). On a year-to-date basis, CVS stock has underperformed by a large margin both in absolute and relative terms. It suffered a loss of more than 10% year-to-date, while SPY delivered a total return of 4.5%.  Seeking Al ...